Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: A nested case-control study of the Drakenstein Child Health Study

The Lancet Respiratory Medicine

Volumn 4, Issue 6, 2016, Pages 463-472

  Zar, Heather J ^a,b   Barnett, Whitney ^a,b   Stadler, Attie ^a,b   Gardner Lubbe, Sugnet ^b   Myer, Landon ^b   Nicol, Mark P ^b,c  

^a RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ADENOVIRIDAE; AGE; ARTICLE; BLOOD SAMPLING; BOCAPARVOVIRUS; BORDETELLA PERTUSSIS; CASE CONTROL STUDY; CHILD; CHILD HEALTH; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATALITY; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INCIDENCE; INFANT; INFLUENZA VIRUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; NOSE SMEAR; PARAMYXOVIRINAE; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOUTH AFRICAN; SPUTUM EXAMINATION; THROAT CULTURE; VACCINATION; CROSS-SECTIONAL STUDY; HOSPITALIZATION; ISOLATION AND PURIFICATION; ORTHOMYXOVIRIDAE; PNEUMOVIRUS; PRESCHOOL CHILD; SOUTH AFRICA; SPUTUM; STATISTICS AND NUMERICAL DATA; VIROLOGY;

BORDETELLA PERTUSSIS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALE; ORTHOMYXOVIRIDAE; PNEUMOCOCCAL VACCINES; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUSES; SOUTH AFRICA; SPUTUM;

EID: 84964691722     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)00096-5     Document Type: Article

References (29)

1. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015, 385:430-440.
2. Campbell H, Nair H Child pneumonia at a time of epidemiological transition. Lancet Glob Health 2015, 3:e65-e66.
3. Theodoratou E, Johnson S, Jhass A, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol 2010, 39(suppl 1):i172-i185.
4. Angoulvant F, Levy C, Grimprel E, et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis 2014, 58:918-924.
5. Tregnaghi MW, Saez-Llorens X, Lopez P, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Med 2014, 11:e1001657.
6. Simonsen L, Taylor RJ, Schuck-Paim C, Lustig R, Haber M, Klugman KP Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. Lancet Respir Med 2014, 2:387-394.
7. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med 2015, 372:835-845.
8. Rhedin S, Lindstrand A, Hjelmgren A, et al. Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study. Thorax 2015, 70:847-853.
9. Murdoch DR, O'Brien KL, Driscoll AJ, et al. Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis 2012, 54(suppl 2):S146-S152.
10. Planting NS, Visser GL, Nicol MP, Workman L, Isaacs W, Zar HJ Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis 2014, 18:8-12.
11. Hammitt LL, Murdoch DR, Scott JA, et al. Specimen collection for the diagnosis of pediatric pneumonia. Clin Infect Dis 2012, 54(suppl 2):S132-S139.
12. le Roux DM, Myer L, Nicol MP, Zar HJ Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study. Lancet Glob Health 2015, 3:e95-103.
13. Zar HJ, Barnett W, Myer L, Stein DJ, Nicol MP Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study. Thorax 2015, 70:592-594.
14. IMCI chart booklet 2014, WHO, World Health Organization, Geneva, (accessed Aug 28, 2015). http://www.who.int/maternal_child_adolescent/documents/IMCI_chartbooklet/en/.
15. Vanker A, Barnett W, Nduru PM, Gie RP, Sly PD, Zar HJ Home environment and indoor air pollution exposure in an African birth cohort study. Sci Total Environ 2015, 536:362-367.
16. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl 2006, 450:76-85. WHO Multicentre Growth Reference Study Group.
17. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
18. Hammitt LL, Kazungu S, Morpeth SC, et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis 2012, 54(suppl 2):S190-S199.
19. Berkley JA, Munywoki P, Ngama M, et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 2010, 303:2051-2057.
20. Shi T, McLean K, Campbell H, Nair H Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health 2015, 5:010408.
21. Zar HJ, Polack FP Childhood pneumonia: the role of viruses. Thorax 2015, 70:811-812.
22. Guvenel AK, Chiu C, Openshaw PJ Current concepts and progress in RSV vaccine development. Expert Rev Vaccines 2014, 13:333-344.
23. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007, 369:1440-1451.
24. Madhi SA, Klugman KP A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004, 10:811-813.
25. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014, 384:1521-1528.
26. De Schutter I, De Wachter E, Crokaert F, et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis 2011, 52:1437-1444.
27. Greenberg D, Givon-Lavi N, Ben-Shimol S, Ziv JB, Dagan R Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. Vaccine 2015, 33:4623-4629.
28. Honkinen M, Lahti E, Osterback R, Ruuskanen O, Waris M Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect 2012, 18:300-307.
29. Vaccine goal indicators 2015, The Global Alliance for Vaccines and Immunisation, The Global Alliance for Vaccines and Immunisation, Switzerland, (accessed Aug 28, 2015). http://www.gavi.org/results/goal-level-indicators/vaccine-goal-indicators/.